Gelsolin as therapeutic target in Alzheimer's disease

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.6, 2010-06, pp. : 585-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4958-4968

Bentham Science Publishers

Access to resources Recommend Favorite

The Cell Cycle and Hormonal Fluxes in Alzheimer Disease: A Novel Therapeutic Target

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 691-697

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Serotonin in Alzheimer's Disease: A New Therapeutic Target?

By Geldenhuys Werner J. >

CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. : 765-781

Adis International

Access to resources Recommend Favorite

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer’s Disease

Current Drug Discovery Technologies, Vol. 11, Iss. 4, 2014-01 ,pp. : 243-258

Bentham Science Publishers

Access to resources Recommend Favorite